IBEX Technologies Inc. IBEX Technologies Inc.

IBEX Technologies Inc.

IBT

Pozycja w akcjach #28825
Founded in 1972 and based in Montreal, Canada, IBEX Technologies Inc.... Founded in 1972 and based in Montreal, Canada, IBEX Technologies Inc. specializes in the production and global distribution of enzymes tailored for biomedical applications. The company's reach extends to Canada, the United States, Germany, and the United Kingdom, as well as other international markets. Its extensive product catalog features recombinant glycosaminoglycan lyases, such as Heparinase I, II, and III, along with Chondroitinase AC and B. Furthermore, IBEX offers collagen ELISAs designed to investigate the synthesis and breakdown of connective tissue components, complementing these with collagen antibodies and diamine oxidase liquid. They are also a key provider of arthritis assays, essential for research into osteoarthritis. Beyond their product lines, IBEX delivers lyophilization services for disposable medical device parts, in addition to custom fermentation and contract manufacturing capabilities. Their diverse client base encompasses medical device fabricators, quality control facilities, producers of low molecular weight heparin, and academic research institutions.
Cena akcji
$1.05
Ostatnia synchronizacja: 2024-04-11
Kapitalizacja rynkowa
$23.31M
Zmiana (1 dzień)
-0.01%
Zmiana (1 rok)
5.21%
Kraj
CA
Handel IBEX Technologies Inc. (IBT)

Kategoria

Healthcare
Historia stopy dywidendy dla IBEX Technologies Inc. (IBT)
Stopa dywidendy (TTM) dla IBEX Technologies Inc. (symbol akcji: IBT) na dzień 2026 wynosi: 0
Średnia stopa dywidendy z ostatnich 5 lat: 0.00%
Historia stopy dywidendy dla IBEX Technologies Inc. (IBT) od 2026 do 2026
Stopa dywidendy na koniec każdego roku (TTM)
Rok Stopa dywidendy Zmień
Za mało danych dla podanych dat.
Stopy dywidendy (TTM) dla podobnych firm lub konkurencji
Firma Stopa dywidendy Kraj
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
0.00%
US
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
0.00%
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
2.17%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
0.00%
CH
Argenx SE Argenx SE
Argenx SE
ARGX.US
0.00%
NL